Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University of Para, Belem, Brazil.
Laboratory of Molecular Pharmacology, Institute of Biological Sciences, Federal University of Para, Belem, Brazil.
J Trace Elem Med Biol. 2019 Mar;52:100-110. doi: 10.1016/j.jtemb.2018.12.001. Epub 2018 Dec 6.
The mercury-related central nervous system disorders have been extensively studied on animal models and human beings. However, clinical evidences of which neurological changes are in fact associated with mercury exposure remains controversial. This systematic review (Prospero registration under the number CRD42016041760) aimed to elucidate the association of methylmercury (MeHg) exposure with neurological alteration in populations living in MeHg-endemic risk area. A systematic search was performed according to the Preferred Reporting Items for Systematic Review and Meta-Analysis criteria using available databases PubMed, LILACS, Scopus, Web of Science, The Cochrane Library, OpenGrey and Google Scholar. A search of the following terms: "methylmercury compounds", "organomercury compounds", "neurologic manifestations", "memory disorders", "neurobehavioral manifestations" and "communication disorders" were performed in a systematic way. Studies focusing on MeHg exposure and subsequent neurological alteration on humans (>13 years) were included. Evaluation of methodological quality and risk of bias as well as the level of evidence was performed. Our results have identified 470 studies and six articles were eligible for systematic review inclusion criteria. The studies suggested alterations related to the psychosensory, motor and coordination system, as well as motor speech, hearing, visual impairment, mood alterations and loss of intelligent quotient. Of all the six studies, two presented a high risk of bias, with methodological problems related to the confounding factors and all studies presented evidence level ranged from very low to low. In this way our results revealed that a definitive demonstration of an association of MeHg and neurological alterations in human beings is still a pending subject. Future studies in this topic should take into consideration more confident and reliable methods to answer this question.
汞相关的中枢神经系统疾病在动物模型和人类中已经得到了广泛的研究。然而,实际上哪些神经变化与汞暴露有关的临床证据仍然存在争议。本系统评价(Prospero 注册号为 CRD42016041760)旨在阐明生活在甲基汞(MeHg)流行风险地区的人群中,MeHg 暴露与神经改变之间的关系。根据系统评价和荟萃分析的首选报告项目标准,使用现有的数据库 PubMed、LILACS、Scopus、Web of Science、The Cochrane Library、OpenGrey 和 Google Scholar 进行了系统搜索。系统地搜索了以下术语:“甲基汞化合物”、“有机汞化合物”、“神经表现”、“记忆障碍”、“神经行为表现”和“沟通障碍”。研究重点是 MeHg 暴露及其对人类(>13 岁)后续神经改变。评估了方法学质量和偏倚风险以及证据水平。我们的研究结果确定了 470 项研究,其中有 6 项符合系统评价纳入标准。这些研究表明,与心理感觉、运动和协调系统以及运动言语、听力、视力障碍、情绪改变和智商丧失有关的改变。在这 6 项研究中,有 2 项研究存在高偏倚风险,方法学问题与混杂因素有关,所有研究的证据水平均为极低至低。因此,我们的研究结果表明,在人类中,MeHg 与神经改变之间存在关联的明确证据仍然是一个悬而未决的问题。未来在这一主题的研究应该考虑更有信心和可靠的方法来回答这个问题。